疑难病杂志
疑難病雜誌
의난병잡지
JOURNAL OF DIFFICULT AND COMPLICATED CASES
2015年
9期
925-928
,共4页
无创双水平正压通气%支气管哮喘,重症%临床疗效
無創雙水平正壓通氣%支氣管哮喘,重癥%臨床療效
무창쌍수평정압통기%지기관효천,중증%림상료효
Noninvasive bi level positive pressure ventilation%Bronchial asthma,severe%Clinical curative effect
目的:观察无创双水平正压通气(NIPPV)在重症支气管哮喘患者中的治疗价值。方法选取2012年1月—2014年1月住院治疗的重症支气管哮喘患者60例,按随机数字表法分为观察组和对照组各30例。对照组予以氧疗+药物治疗,观察组在对照组基础上加用NIPPV治疗。对比2组患者治疗前及治疗后1、12、24、72 h的动脉血气指标、肺功能变化,并随访3个月后的临床疗效。结果与治疗前比较,2组患者治疗1、12、24、72 h后的pH、PaO2和SaO2逐步上升,PaCO2逐步下降( P均<0.05);观察组治疗1、12、24、72 h后的pH、PaO2和SaO2均高于对照组,PaCO2低于对照组( P均<0.05)。与治疗前比较,治疗1周后,2组患者的FEV1、FEV1/FVC、PEF均显著升高(P <0.05),且观察组的FEV1、FEV1/FVC和PEF较对照组显著升高( P <0.05)。随访3个月后观察组的临床疗效显著高于对照组(93.33% vs.63.34%,χ2=3.977, P <0.05)。2组患者并发症发生率比较差异无统计学意义(20.0% vs.10.0%, P >0.05)。结论在氧疗和药物治疗的基础上加用NIPPV,可以改善重症支气管哮喘患者的通气情况和肺功能,临床疗效可靠。
目的:觀察無創雙水平正壓通氣(NIPPV)在重癥支氣管哮喘患者中的治療價值。方法選取2012年1月—2014年1月住院治療的重癥支氣管哮喘患者60例,按隨機數字錶法分為觀察組和對照組各30例。對照組予以氧療+藥物治療,觀察組在對照組基礎上加用NIPPV治療。對比2組患者治療前及治療後1、12、24、72 h的動脈血氣指標、肺功能變化,併隨訪3箇月後的臨床療效。結果與治療前比較,2組患者治療1、12、24、72 h後的pH、PaO2和SaO2逐步上升,PaCO2逐步下降( P均<0.05);觀察組治療1、12、24、72 h後的pH、PaO2和SaO2均高于對照組,PaCO2低于對照組( P均<0.05)。與治療前比較,治療1週後,2組患者的FEV1、FEV1/FVC、PEF均顯著升高(P <0.05),且觀察組的FEV1、FEV1/FVC和PEF較對照組顯著升高( P <0.05)。隨訪3箇月後觀察組的臨床療效顯著高于對照組(93.33% vs.63.34%,χ2=3.977, P <0.05)。2組患者併髮癥髮生率比較差異無統計學意義(20.0% vs.10.0%, P >0.05)。結論在氧療和藥物治療的基礎上加用NIPPV,可以改善重癥支氣管哮喘患者的通氣情況和肺功能,臨床療效可靠。
목적:관찰무창쌍수평정압통기(NIPPV)재중증지기관효천환자중적치료개치。방법선취2012년1월—2014년1월주원치료적중증지기관효천환자60례,안수궤수자표법분위관찰조화대조조각30례。대조조여이양료+약물치료,관찰조재대조조기출상가용NIPPV치료。대비2조환자치료전급치료후1、12、24、72 h적동맥혈기지표、폐공능변화,병수방3개월후적림상료효。결과여치료전비교,2조환자치료1、12、24、72 h후적pH、PaO2화SaO2축보상승,PaCO2축보하강( P균<0.05);관찰조치료1、12、24、72 h후적pH、PaO2화SaO2균고우대조조,PaCO2저우대조조( P균<0.05)。여치료전비교,치료1주후,2조환자적FEV1、FEV1/FVC、PEF균현저승고(P <0.05),차관찰조적FEV1、FEV1/FVC화PEF교대조조현저승고( P <0.05)。수방3개월후관찰조적림상료효현저고우대조조(93.33% vs.63.34%,χ2=3.977, P <0.05)。2조환자병발증발생솔비교차이무통계학의의(20.0% vs.10.0%, P >0.05)。결론재양료화약물치료적기출상가용NIPPV,가이개선중증지기관효천환자적통기정황화폐공능,림상료효가고。
Objective To observe the therapeutic value of noninvasive bi level positive pressure ventilation ( NIPPV) in patients with severe bronchial asthma .Methods From January 2012 to January 2014 , selected 60 patients with severe bronchial asthma , according to the random number table method , they were divided into the observation group and the control group with 30 cases in each group .The control group was treated with oxygen therapy plus medication , and the observation group was treated with NIPPV on the basis of treatment in the control group .The blood gas and pulmonary function before treatment and 1h, 12h, 24h, 72 h after treatment were compared , and followed up 3 months of the clinical effect .Results Compared with before treatment , 2 groups of patients 1h, 12, 24 h and 72 h after treatment, the pH, PaO2 and SaO2 gradually increased, PaCO2 gradually decreased ( P <0.05);observation group 1h, 12h, 24 h and 72 h after treatment’s pH, PaO2 and SaO2 were higher than those of the control group , and PaCO2 was lower than control group ( P <0.05).Compared with before treatment , after 1 week of treatment , patients in the two groups ’ FEV1 , FEV1/FVC and PEF were significantly in-creased ( P <0.05), and the observation group’s FEV1, FEV1/FVC and PEF were significantly increased than control group ( P <0.05).After 3 months of follow-up, the clinical curative effect of observation group was significantly better than the control group (93.33%vs.63.34%,χ2 =3.977, P <0.05).The incidence of complications between the 2 groups did not show significant differences (20.0% vs.10.0%, P >0.05).Conclusion Based on oxygen therapy and drug treatment , NIPPV can improve ventilation of patients with severe bronchial asthma and lung function with reliable clinical curative effect .